CSIMarket
 


Genmark Diagnostics Inc   (GNMK)
Other Ticker:  
 
 

GNMK's Capital Expenditures Growth by Quarter and Year

Genmark Diagnostics Inc 's Capital Expenditures results by quarter and year




GNMK Capital Expenditures (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 9.90 0.90 1.52 1.00
III Quarter September 6.17 0.73 0.14 1.78
II Quarter June 0.75 0.13 1.39 0.65
I Quarter March 0.95 0.33 -0.47 1.89
FY   17.77 2.09 2.58 5.32



GNMK Capital Expenditures fourth quarter 2020 Y/Y Growth Comment
Genmark Diagnostics Inc achieved in the fourth quarter 2020, above Company average Capital Expenditures surge of 1000.22% year on year, to $ 9.90 millions.

Looking into fourth quarter 2020 results within Medical Equipment & Supplies industry 14 other companies have achieved higher Capital Expenditures growth. While Genmark Diagnostics Inc ' s Capital Expenditures doubling of 1000.22% ranks overall at the positon no. 101 in the fourth quarter 2020.




GNMK Capital Expenditures ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December 1000.22 % -40.79 % 52 % -61.54 %
III Quarter September 745.21 % 421.43 % -92.13 % -34.07 %
II Quarter June 476.92 % -90.65 % 113.85 % -54.86 %
I Quarter March 187.88 % - - 6.78 %
FY   750.33 % -18.99 % -51.5 % -37.49 %

Financial Statements
Genmark Diagnostics Inc 's fourth quarter 2020 Capital Expenditures $ 9.90 millions GNMK's Income Statement
Genmark Diagnostics Inc 's fourth quarter 2019 Capital Expenditures $ 0.90 millions Quarterly GNMK's Income Statement
New: More GNMK's historic Capital Expenditures Growth >>


GNMK Capital Expenditures (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December 60.49 % 23.29 % 985.71 % -43.82 %
III Quarter September 722.67 % 461.54 % -89.93 % 173.85 %
II Quarter June -21.05 % -60.61 % - -65.61 %
I Quarter March 5.56 % -78.29 % - -27.31 %
FY (Year on Year)   750.33 % -18.99 % -51.5 % -37.49 %




Capital Expenditures fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #45
Overall #101

Capital Expenditures Y/Y Growth Statistics
High Average Low
1001.45 % 134.75 % -92.36 %
(Dec 31 2020)   (Sep 30 2018)
Capital Expenditures fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #15
Healthcare Sector #45
Overall #101
Capital Expenditures Y/Y Growth Statistics
High Average Low
1001.45 % 134.75 % -92.36 %
(Dec 31 2020)   (Sep 30 2018)

Capital Expenditures by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Genmark Diagnostics Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
1013.97 % 77.88 % -100 %
(Dec 31 2018)  


GNMK's IV. Quarter Q/Q Capital Expenditures Comment
Genmark Diagnostics Inc achieved in the IV. Quarter 2020 below company average Capital Expenditures jump of 60.49% quarter on quarter, to $ 9.90 millions.

Albeit the IV. Quarter 2020 GNMK's Capital Expenditures sequential growth was below the average of 77.88 %, that was yet promising news, as the current improvement, transcends the 23.29% Capital Expenditures growth in the IV. Quarter a year ago

Within Medical Equipment & Supplies industry 47 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Genmark Diagnostics Inc 's Capital Expenditures growth quarter on quarter, overall rank is 848.


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #205
Overall #848
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #48
Healthcare Sector #205
Overall #848
Capital Expenditures Q/Q Growth Statistics
High Average Low
1013.97 % 77.88 % -100 %
(Dec 31 2018)  


GNMK's IV. Quarter Q/Q Capital Expenditures Comment
Genmark Diagnostics Inc achieved in the IV. Quarter 2020 below company average Capital Expenditures jump of 60.49% quarter on quarter, to $ 9.90 millions.

IV. Quarter 2020 GNMK's Capital Expenditures quarter on quarter growth were a mixed bag, although beneath the regular rise of 77.88 %, yet it shows absolute acceleration measured to the 23.29% in the same quarter a year ago Eleanora Ricci, Medical Equipment & Supplies industry expert from New York wrote.

Within Medical Equipment & Supplies industry 47 other companies have achieved higher Capital Expenditures quarter on quarter growth. While Genmark Diagnostics Inc 's Capital Expenditures growth quarter on quarter, overall rank is 848.


Genmark Diagnostics Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Capital Expenditures 12 Months Ending $ 17.78 $ 8.77 $ 3.33 $ 2.71 $ 2.09
Y / Y Capital Expenditures Growth (TTM) 749.71 % 223.97 % 57.13 % -19.63 % -18.76 %
Year on Year Capital Expenditures Growth Overall Ranking # 1694 # 132 # 562 # 511 # 2070
Seqeuential Capital Expenditures Change (TTM) 102.62 % 163.61 % 22.76 % 29.59 % -22.75 %
Seq. Capital Expenditures Growth (TTM) Overall Ranking # 1818 # 64 # 94 # 35 # 2604




Cumulative Capital Expenditures growth Comment
With 749.71% annual Capital Expenditures growth, Genmark Diagnostics Inc would report a record annual Capital Expenditures surge if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 292 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 132 to 1694.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
749.71 %
36.2 %
-70.21 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 293
Overall # 1694

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
749.71 %
36.2 %
-70.21 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 73
Sector # 302
S&P 500 # 1818
Cumulative Capital Expenditures growth Comment
With 749.71% annual Capital Expenditures growth, Genmark Diagnostics Inc would report a record annual Capital Expenditures surge if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 292 other companies have achieved higher trailing twelve month Capital Expenditures growth. While Capital Expenditures growth total ranking has deteriorated compare to previous quarter from 132 to 1694.

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
749.71 %
36.2 %
-70.21 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 73
Healthcare Sector # 293
Overall # 1694

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
749.71 %
36.2 %
-70.21 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry # 73
Sector # 302
S&P 500 # 1818




Other Capital Expenditures Growth
Medical Equipment & Supplies Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
GNMK's Capital Expenditures Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for GNMK's Competitors
Capital Expenditures Growth for Genmark Diagnostics Inc 's Suppliers
Capital Expenditures Growth for GNMK's Customers

You may also want to know
GNMK's Annual Growth Rates GNMK's Profitability Ratios GNMK's Asset Turnover Ratio GNMK's Dividend Growth
GNMK's Roe GNMK's Valuation Ratios GNMK's Financial Strength Ratios GNMK's Dividend Payout Ratio
GNMK's Roa GNMK's Inventory Turnover Ratio GNMK's Growth Rates GNMK's Dividend Comparisons



Companies with similar Capital Expenditures surge for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Dec 31 2020
Armata Pharmaceuticals Inc 1,642.86%$ 1,642.857 millions
T2 Biosystems Inc 1,357.69%$ 1,357.692 millions
Vanda Pharmaceuticals Inc 1,320.59%$ 1,320.588 millions
Beyond Air Inc 1,225.33%$ 1,225.333 millions
Co diagnostics Inc 1,194.08%$ 1,194.075 millions
Hepion Pharmaceuticals inc 1,148.10%$ 1,148.100 millions
Sinovac Biotech Ltd1,101.07%$ 1,101.073 millions
Interpace Biosciences Inc 1,053.85%$ 1,053.846 millions
Reshape Lifesciences Inc 1,042.86%$ 1,042.857 millions
F star Therapeutics Inc 1,034.38%$ 1,034.375 millions
Igm Biosciences Inc 1,018.00%$ 1,018.000 millions
Genmark Diagnostics Inc 1,001.45%$ 1,001.446 millions
Frequency Therapeutics Inc 949.41%$ 949.406 millions
Cue Biopharma Inc 945.68%$ 945.678 millions
Nemaura Medical Inc 923.56%$ 923.560 millions
Evofem Biosciences Inc 907.80%$ 907.801 millions
Protalix Biotherapeutics inc 882.14%$ 882.143 millions
Acadia Pharmaceuticals Inc 865.70%$ 865.700 millions
Genocea Biosciences Inc 839.04%$ 839.041 millions
Pulmatrix Inc 822.22%$ 822.222 millions
Ocugen Inc 817.99%$ 817.992 millions
Constellation Pharmaceuticals Inc768.75%$ 768.750 millions
Chinook Therapeutics Inc 767.53%$ 767.532 millions
Alpha Pro Tech Ltd 759.85%$ 759.848 millions
Sonoma Pharmaceuticals Inc 755.56%$ 755.556 millions
Volitionrx Limited731.08%$ 731.079 millions
Cormedix Inc 717.53%$ 717.531 millions
Zynex inc 707.14%$ 707.143 millions
Odonate Therapeutics Inc 700.00%$ 700.000 millions
Arcus Biosciences Inc 675.00%$ 675.000 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com